Extruded depot form with controlled release of active ingredients
DE102019110397A1
Transdermal delivery system with aromatase inhibitor in a supersaturated matrix
DE102019110398A1
Transdermal delivery system with aromatase inhibitor
DE102018120505A1
Preventing the crystallization of drugs in transdermal delivery systems
DE102018110792A1
Transdermal application system with safety adhesive layer
DE102018106217A1
applicator
DE102017124627A1
Transdermal delivery system containing a dopamine agonist
DE102017113166A1
Depot form for dispensing an estrogen active ingredient
DE102017112543A1
Overtape for a transdermal delivery system
DE102017106216A1
Extruded depot form for sustained release of active ingredient
EP3297591A1
Plaster with bi-elastic backing layer
DE102016105889A1
Transdermal application system with information layer
DE102015006599A1
Plaster with bielastic backing layer
DE102014007650A1
Plaster with bielastic backing layer
DE102013011399A1
Rod-shaped biodegradable implant useful for maintenance therapy in schizophrenia in patients comprises risperidone
DE102013008726A1
Plaster with removal aid
DE102013008727A1
Plaster with notched peel-off film
DE102011116973A1
Implanter for application of implants in human area, has sleeve, cylinder, needle, mandrel movable in needle, needle return spring and partially transparent chamber for implant
DE102011100619A1
Therapeutic system, useful to treat chronic pain, comprises active agent impermeable carrier, active agent reservoir containing e.g. opioid receptor agonist, optionally active agent-permeable membrane and active agent impermeable layer
DE102010026879A1
Transdermal system, useful for indicating and preventing multiple sclerosis, immunomodulator including quinolines or isoxazoles, metabolite forming groups, skin protective layer, a reservoir and a carrier impermeable to active substance
